Ptc Therapeutics (PTCT) Other Non Operating Income (2012 - 2026)

Ptc Therapeutics' Other Non Operating Income history runs 15 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• On a quarterly basis, Other Non Operating Income rose 125.52% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was -$10.2 million, a 28.83% increase from a year earlier, with the FY2025 full-year figure at -$18.1 million, down 182.73% from the prior year.
• Other Non Operating Income advanced to $1.6 million in Q1 2026 per PTCT's latest filing, from -$12.5 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $35.1 million in Q4 2022 and bottomed at -$38.1 million in Q3 2022.
• The 5-year median for Other Non Operating Income is -$2.0 million (2024), against an average of -$4.9 million.
• Across the five-year window, Other Non Operating Income sank 1183.82% in 2022 and surged 447.33% in 2025, its largest moves.
• Year by year, Other Non Operating Income stood at $35.1 million in 2022, then slumped by 104.81% to -$1.7 million in 2023, then tumbled by 142.21% to -$4.1 million in 2024, then tumbled by 206.67% to -$12.5 million in 2025, then soared by 112.82% to $1.6 million in 2026.
• Per Business Quant, the three latest PTCT Other Non Operating Income figures stand at $1.6 million (Q1 2026), -$12.5 million (Q4 2025), and $6.5 million (Q3 2025).